Stay updated on REOLYSIN in KRAS Mutant CRC Clinical Trial
Sign up to get notified when there's something new on the REOLYSIN in KRAS Mutant CRC Clinical Trial page.

Latest updates to the REOLYSIN in KRAS Mutant CRC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe revision tag changed from v3.6.4 to v3.6.5, indicating an internal update to the page template. This does not alter visible study details or user-facing content.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 on the page, signaling a new build/version. This appears to be a maintenance update that does not modify the study information or user-visible content.SummaryDifference0.1%

- Check53 days agoChange DetectedFooter revision updated from v3.6.2 to v3.6.3, indicating a minor page update. The change does not affect study details, eligibility, outcomes, or user interaction.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page footer now displays Revision: v3.6.2, replacing Revision: v3.6.0. This appears to be a minor site update that does not affect the study details or user-facing content.SummaryDifference0.1%

- Check74 days agoChange DetectedRecruitment status updated to No longer looking for participants, and new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment heading was reformatted and the revision version updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check81 days agoChange DetectedFooter revision tag updated from Revision: v3.5.4 to Revision: v3.5.5. This indicates a minor site update and does not modify study information.SummaryDifference0.1%

Stay in the know with updates to REOLYSIN in KRAS Mutant CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REOLYSIN in KRAS Mutant CRC Clinical Trial page.